Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2022Journal of the Formosan Medical AssociationOpen Access

Outcomes of pediatric patients supported with ventricular assist devices single center experience

View Full Paper
Ask AI
Bookmark
Share

Key result

Ventricular assist device support in pediatric patients resulted in positive outcomes (alive on device, bridge to transplantation, or recovery) in 72.7% at 1 month and 67.7% at 6 months.

Why the study?

Pediatric VAD implantations have increased, but Asian pediatric heart centers had not participated in multicenter Western registries, prompting this report of single-center outcomes.

Population

33 patients aged <18 years undergoing VAD implantation at a single institution

Design

Single-center cohort study

Follow-up

6 months

Authors

HFHsun‐Yi FuNational Taiwan University HospitalHCHeng‐Wen ChouNational Taiwan UniversityCLChun‐Fu LaiNational Taiwan University

Discussion

Loading...

Member takes

Implication

Single-center Asian pediatric VAD data; leaves open generalizability and optimal strategies pending larger prospective registries.

Study Design

Type

Cohort (n=33)

Multicenter

No

Structured PICO

P
Population
33 pediatric patients aged <18 years who underwent ventricular assist device implantation for conditions including acute fulminant myocarditis and dilated cardiomyopathy.
E
Exposure
Ventricular assist device (VAD) implantation (paracorporeal continuous-flow pump most frequent, n=27)
O
Outcome
Positive outcomes (composite of alive on device, bridge to transplantation, or recovery) at 1, 3, and 6 monthscomposite

Pediatric VAD implantation in an Asian center demonstrated favorable outcomes, with 67.7% of patients achieving positive outcomes (alive on device, bridge to transplant, or recovery) at 6 months.

Cite This Study

Fu et al. (2022) conducted a cohort in Pediatric heart failure requiring ventricular assist device (n=33). Ventricular assist device (VAD) was evaluated on Positive outcomes (alive on device, bridge to transplantation or recovery) at 1 month. Ventricular assist device support in pediatric patients resulted in positive outcomes (alive on device, bridge to transplantation, or recovery) in 72.7% at 1 month and 67.7% at 6 months.

synapsesocial.com/papers/6a9e473fc448d60cdc3682abhttps://doi.org/10.1016/j.jfma.2022.09.008

Topics

Mechanical circulatory supportHeart transplantationHeart failureHFrEF treatmentCongenital heart disease adults
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ventricular assist device–promoted recovery and technical aspects of explant2021 · 14 citations
  2. 2Mechanical left ventricular support as a bridge to cardiac transplantation in childhood1991 · 126 citations
  3. 3Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure])2020 · 227 citations
  4. 4Neurological Complications and Outcomes in the Berlin Heart EXCOR ® Pediatric Investigational Device Exemption Trial2015 · 103 citations
  5. 5OPTN/SRTR 2019 Annual Data Report: Heart2021 · 128 citations